RS53162B - Polietilen glikolni preparati u kontroli relapsa herpes labialis-a, herpes genitalis-a i herpes zoster-a - Google Patents
Polietilen glikolni preparati u kontroli relapsa herpes labialis-a, herpes genitalis-a i herpes zoster-aInfo
- Publication number
- RS53162B RS53162B RS20140058A RSP20140058A RS53162B RS 53162 B RS53162 B RS 53162B RS 20140058 A RS20140058 A RS 20140058A RS P20140058 A RSP20140058 A RS P20140058A RS 53162 B RS53162 B RS 53162B
- Authority
- RS
- Serbia
- Prior art keywords
- peg
- polyethylene glycol
- relapse
- herpes
- application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36232910P | 2010-07-08 | 2010-07-08 | |
| PCT/IB2011/001919 WO2012004669A1 (en) | 2010-07-08 | 2011-07-08 | Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS53162B true RS53162B (sr) | 2014-06-30 |
Family
ID=44588123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20140058A RS53162B (sr) | 2010-07-08 | 2011-07-08 | Polietilen glikolni preparati u kontroli relapsa herpes labialis-a, herpes genitalis-a i herpes zoster-a |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US9814743B2 (enExample) |
| EP (1) | EP2563374B1 (enExample) |
| JP (1) | JP5858994B2 (enExample) |
| KR (1) | KR101881175B1 (enExample) |
| CN (1) | CN103079574B (enExample) |
| AU (1) | AU2011275458B2 (enExample) |
| CA (1) | CA2803228C (enExample) |
| DK (1) | DK2563374T3 (enExample) |
| ES (1) | ES2442928T3 (enExample) |
| HR (1) | HRP20140135T1 (enExample) |
| IL (1) | IL223582A (enExample) |
| MX (1) | MX2012014783A (enExample) |
| PL (1) | PL2563374T3 (enExample) |
| PT (1) | PT2563374E (enExample) |
| RS (1) | RS53162B (enExample) |
| RU (1) | RU2643763C2 (enExample) |
| SG (1) | SG186937A1 (enExample) |
| SI (1) | SI2563374T1 (enExample) |
| WO (1) | WO2012004669A1 (enExample) |
| ZA (1) | ZA201300177B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9814743B2 (en) | 2010-07-08 | 2017-11-14 | Devirex Ag | Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
| WO2013102885A1 (en) | 2012-01-06 | 2013-07-11 | Devirex Ag | Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
| WO2014130432A1 (en) | 2013-02-19 | 2014-08-28 | Johnson & Johnson Consumer Companies, Inc. | Methods and compositions for improving appearance and formation of scar tissue |
| ES2538335T3 (es) * | 2013-05-14 | 2015-06-19 | Najöpharm Gmbh I.G. | Combinación de ácido poliacrílico y 2-amino-2-metilpropanol para uso en el tratamiento de infecciones por herpes |
| WO2018095576A1 (en) * | 2016-11-28 | 2018-05-31 | Aicuris Anti-Infective Cures Gmbh | Topical pharmaceutical formulation comprising n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide |
| CN114981286B (zh) | 2019-05-03 | 2026-02-13 | 豪夫迈·罗氏有限公司 | 降低从纯化平台获得的组合物中酶水解活性速率的方法 |
| EP4090666A1 (en) | 2020-01-15 | 2022-11-23 | F. Hoffmann-La Roche AG | Methods to decrease impurities from recombinant protein manufacturing processes |
| US20210330700A1 (en) * | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols |
| EP4355297A1 (de) * | 2020-04-30 | 2024-04-24 | Ninoderm UG (Haftungsbeschränkt) | Behandlungsmittel zur antiviralen therapie, applikator und verfahren zur herstellung eines behandlungsmittels |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4603122A (en) | 1979-08-17 | 1986-07-29 | Blough Herbert A | Antiviral agent against herpes virus infections |
| GB2080682B (en) * | 1980-07-30 | 1984-03-28 | Ciba Geigy Ag | Antiherpetically active lipstick |
| EP0087161A3 (en) | 1982-02-24 | 1984-04-04 | Key Pharmaceuticals, Inc. | Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament |
| US5232700A (en) * | 1990-11-14 | 1993-08-03 | The Administrators Of The Tulane Educational Fund | Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient |
| NL9500216A (nl) * | 1995-02-06 | 1996-09-02 | Bio Pharma Sciences Bv | Farmaceutische samenstelling voor de behandeling van herpes. |
| US6045823A (en) * | 1996-09-19 | 2000-04-04 | Dragoco Gerberding & Co. Ag | Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same |
| GB9902227D0 (en) * | 1999-02-01 | 1999-03-24 | Cipla Limited | Pharmaceutical composition for topical administration |
| US8030260B2 (en) * | 2005-03-25 | 2011-10-04 | Chemsil Silicones, Inc | Pre-shave compositions and methods of using same |
| DE202005007363U1 (de) | 2005-05-04 | 2005-07-14 | Anton Hübner GmbH & Co. KG | Gegen Herpesbläschen verwendbare Kieselsäurezusammensetzungen |
| SG177217A1 (en) | 2007-01-17 | 2012-01-30 | Devirex Ag | Cyclodextrin formulations |
| US9814743B2 (en) | 2010-07-08 | 2017-11-14 | Devirex Ag | Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
| WO2013102885A1 (en) | 2012-01-06 | 2013-07-11 | Devirex Ag | Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
-
2011
- 2011-07-08 US US13/704,061 patent/US9814743B2/en not_active Expired - Fee Related
- 2011-07-08 PL PL11754919T patent/PL2563374T3/pl unknown
- 2011-07-08 JP JP2013517583A patent/JP5858994B2/ja active Active
- 2011-07-08 AU AU2011275458A patent/AU2011275458B2/en not_active Ceased
- 2011-07-08 EP EP11754919.6A patent/EP2563374B1/en active Active
- 2011-07-08 SG SG2013000823A patent/SG186937A1/en unknown
- 2011-07-08 MX MX2012014783A patent/MX2012014783A/es active IP Right Grant
- 2011-07-08 RS RS20140058A patent/RS53162B/sr unknown
- 2011-07-08 CN CN201180033948.1A patent/CN103079574B/zh active Active
- 2011-07-08 SI SI201130086T patent/SI2563374T1/sl unknown
- 2011-07-08 KR KR1020137002574A patent/KR101881175B1/ko not_active Expired - Fee Related
- 2011-07-08 RU RU2013100383A patent/RU2643763C2/ru active
- 2011-07-08 CA CA2803228A patent/CA2803228C/en active Active
- 2011-07-08 PT PT117549196T patent/PT2563374E/pt unknown
- 2011-07-08 HR HRP20140135AT patent/HRP20140135T1/hr unknown
- 2011-07-08 DK DK11754919.6T patent/DK2563374T3/da active
- 2011-07-08 WO PCT/IB2011/001919 patent/WO2012004669A1/en not_active Ceased
- 2011-07-08 ES ES11754919.6T patent/ES2442928T3/es active Active
-
2012
- 2012-12-12 IL IL223582A patent/IL223582A/en active IP Right Grant
-
2013
- 2013-01-08 ZA ZA2013/00177A patent/ZA201300177B/en unknown
-
2017
- 2017-11-06 US US15/804,961 patent/US20180055875A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP5858994B2 (ja) | 2016-02-10 |
| CA2803228A1 (en) | 2012-01-12 |
| PL2563374T3 (pl) | 2014-04-30 |
| HK1180969A1 (en) | 2013-11-01 |
| IL223582A (en) | 2017-12-31 |
| WO2012004669A1 (en) | 2012-01-12 |
| EP2563374B1 (en) | 2013-11-13 |
| ZA201300177B (en) | 2014-03-26 |
| CN103079574B (zh) | 2017-04-12 |
| KR20130142992A (ko) | 2013-12-30 |
| US20180055875A1 (en) | 2018-03-01 |
| HRP20140135T1 (hr) | 2014-03-28 |
| RU2643763C2 (ru) | 2018-02-05 |
| SG186937A1 (en) | 2013-02-28 |
| KR101881175B1 (ko) | 2018-07-23 |
| SI2563374T1 (sl) | 2014-01-31 |
| MX2012014783A (es) | 2013-04-03 |
| RU2013100383A (ru) | 2014-08-20 |
| ES2442928T3 (es) | 2014-02-14 |
| AU2011275458B2 (en) | 2014-11-27 |
| PT2563374E (pt) | 2014-01-23 |
| US20130090389A1 (en) | 2013-04-11 |
| CA2803228C (en) | 2019-03-12 |
| EP2563374A1 (en) | 2013-03-06 |
| CN103079574A (zh) | 2013-05-01 |
| JP2013530208A (ja) | 2013-07-25 |
| AU2011275458A1 (en) | 2013-02-28 |
| US9814743B2 (en) | 2017-11-14 |
| DK2563374T3 (da) | 2014-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2011275458B2 (en) | Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster | |
| US20100111883A1 (en) | Cyclodextrin formulations | |
| WO2017011785A1 (en) | Topical antiviral formulations and methods of using the same | |
| Stoopler et al. | Topical and systemic therapies for oral and perioral herpes simplex virus infections | |
| US9144576B2 (en) | Topical antiviral formulations | |
| TW201212925A (en) | Agent for treating inflammatory diseases, which contains adenosine N1-oxide | |
| CN104853759A (zh) | 以gpcr19作用剂作为有效成分的过敏性皮肤疾病的预防或治疗用组成物 | |
| US20110207696A1 (en) | Compositions for treating rosacea | |
| KR101330411B1 (ko) | 증숙 처리된 녹차 추출물을 유효성분으로 함유하는 아토피 피부염 개선용 조성물 | |
| WO2013102885A1 (en) | Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster | |
| HK1180969B (en) | Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster | |
| EP2782585B1 (en) | Antiviral formulations | |
| EP0078533B1 (en) | Medicinal composition for treating skin disorders | |
| BR102016004295A2 (pt) | Composição farmacêutica de medicamento à base de própolis | |
| ITUB20159325A1 (it) | Uso di un estratto o concentrato di gelso nero per la preparazione di prodotti cosmetici o integratori alimentari, e prodotti cosmetici o integratori alimentari cosi preparati |